Jan. 31, 2020 Price forecast | 2 weeks: 2.10% | 1 month: -0.20% | 3 months: -4.59%

MNKD stock forecast

Our latest prediction for MannKind Corp.'s stock price was made on the Jan. 31, 2020 when the stock price was at 1.47$.

In the short term (2weeks), MNKD's stock price should outperform the market by 2.10%. During that period the price should oscillate between -11.06% and +15.34%.

In the medium term (3months), MNKD's stock price should underperform the market by -4.59%. During that period the price should oscillate between -47.14% and +41.37%.

About MannKind Corp.

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and, commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.

At the moment the company generates 63M USD in revenues.

On its last earning announcement, the company reported a loss of -0.24$ per share.

The book value per share is -1.35$

MannKind Corp. website

Three months stock forecastJan. 31, 2020


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
63M 57.10% -47M -74.20% -47M -0.24 - - 184M -1.35 -58M - -61M